The effects of silver dressings on hronic and burns wound healing

British Journal of Nursing

Volumn 19, Issue 15 SUPPL., 2010, Pages

  Elliott, Chris ^a  

^a General Surgery   (United Kingdom)

Author keywords

Burns; Chronic wounds; Dressings; Healing; Silver

Indexed keywords

EID: 77957704737     PISSN: 09660461     EISSN: None     Source Type: Journal    
DOI: 10.12968/bjon.2010.19.sup5.77707     Document Type: Article

References (29)

1. Aucken HM, Ganner M, Murchan S, Cookson BD, Johnson AP (2002) A new UK strain of epidemic methicillin-resistant Staphylococcus aureus (EMRSA- 17) resistant to multiple antibiotics. J Antimicrob Chemother 50(2): 171-175
2. Boosalis MG, McCall JT, Ahrenholz DH, Solem LD, McClain CJ (1987) Serum and urinary silver levels in thermal injury patients. Surgery 101(1): 40-43
3. Bradbury S, Turner A, Ivins N, Harding K (2007) Managing Chronic Wounds with Acticoat Moisture Control. Wounds UK 3(2): 104-109
4. Coombs CJ, Wan AT, Masterton JP, Conyers RA, Pedersen J, Chia YT (1992) Do burn patients have a silver lining? Burns 18(3): 179-184
5. Chaby G, Viseux V, Poulain JF, De Cagny B, Denoeux JP, Lok C (2005) Topical silver sulfadiazine-induced acute renal failure. Ann Dermatol Venereol 132(11 Pt 1):891-893 [French]
6. Dunn K, Edwards-Jones V (2004) The role of Acticoat with nanocrystalline silver in the management of burns. Burns 30(Suppl 1): S1-9
7. Edwards-Jones V (2006) Antimicrobial and barrier effects of silver against methicillin-resistant Staphylococcus aureus. J Wound Care 15(7): 285-290
8. Fong J, Wood F, Fowler B (2004) A silver coated dressing reduces the incidence of early burn wound cellulitis and associated cost of inpatient treatment: comparative patient care audits. Burns 31(5): 562-567
9. Fox CL Jr (1968) Silver sulphadiazine-a new topical therapy for Pseudomonas in burns. Therapy of Pseudomonas infection in burns. Arch Surg 96(2): 184-188
10. Fung MC, Bowen DL (1996) Silver products for medical indications: riskbenefit assessment. J Toxicol Clin Toxicol 34(1): 119-126
11. Gibbins B (2003) The antimicrobial benefits of silver and the relevance of microlattice technology. Ostomy Wound Manage Suppl: 4-7
12. Gibbins B, Warner L (2005) The Role of Antimicrobial Silver Nanotechnology. http://tinyurl.com/2ewhakb (accessed 30 July 2010)
13. Harvard Medical School (2008) Medical Dictionary. www.health.harvard.edu/ dictionary/A.htm (accessed 30 July 2010)
14. Health Protection Agency (2008) Acinetobacter species. http://tinyurl.com/38dlxwt (accessed 30 July 2010)
15. Hiramatsu K, Aritaka N, Hanaki H et al (1997) Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350(9092): 1670-1673
16. Ip M, Lui SL, Poon VK, Lung I, Burd A (2006) Antimicrobial activities of silver dressings: an in vitro comparison. J Med Microbiol 55(pt 1): 59-63
17. Klassen HJ (2001) A historical review of the use of silver in the treatment of burns: renewed interest in silver. Burns 27(3): 301-302
18. Lansdowne AB, Williams A, Chandler S, Benfield S (2005) Silver absorption and antibacterial efficacy of silver dressings. J Wound Care 14(4): 155-160
19. Napoli B, D'arpan N, Massellis A, Massellis M (2005) The local treatment of burns with antibiotics. Ann Burns Fire Disasters 18(3): 65-69
20. Poon VK, Burd A (2004) In vitro cytotoxicity of silver: implication for clinical wound care. Burns 30(2): 140-147
21. Pyrek K (2004) Infection rate reporting: making it add up for patient safety. Infection Control Today 8(11): 32-36
22. Strohal R, Schelling M, Takacs M, Jurecka W, Gruber U, Offner F (2005) Nanocrystalline silver dressings as an efficient anti-MRSA barrier: a new solution to an increasing problem. J Hosp Infect 60(3): 226-230
23. Thomas S, McCubbin P (2003) A comparison of the antimicrobial effects of four silver-containing dressings on three organisms. J Wound Care 12(3): 69-72
24. Ulkür E, Oncül O, Karagöz H, Celiköz B, Cavuslu S (2005) Comparison of silver-coated dressing (Acticoat), chlorhexadine acetate 0.5% (Bactigrass), and silver sulfadiazine 1% (Silverdin) for topical antibacterial effect in Pseudomonas aeruginosa-contaminated, full-skin thickness burn wounds in rats. J Burn Care Rehabil 26(5): 430-433
25. Vermeulen H, van Hattem JM, Storm-Versloot MN, Ubbink DT (2007) Topical silver for treating wounds. Cochrane Database Syst Rev (1): CD005846
26. Wan AT, Conyers RA, Coombs CJ, Masterton JP (1991), Determination of silver in blood, urine, and tissues of volunteers and burn patients. Clin Chem 37(10 Pt 1): 1683-1687
27. White R, Cooper C (2005) Exploring the effects of silver in wound management: What is optimal? J Hosp Infect 60(1): 1-7
28. White R, Cutting K (2006) Exploring the effects of silver in wound management: What is optimal? Wounds 18(11): 307-314
29. Yin HQ, Langford R, Burrell RE (1999) Comparative evaluation of the antimicrobial activity of ACTICOAT antimicrobial barrier dressing. J Burn Care Rehabil 20(3): 195-200